Christopher J. Yuskaitis, Ph.D. - Publications

Affiliations: 
2009 Cell Biology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Neuroscience Biology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Yuskaitis CJ, Parviz M, Loui P, Wan CY, Pearl PL. Neural Mechanisms Underlying Musical Pitch Perception and Clinical Applications Including Developmental Dyslexia. Current Neurology and Neuroscience Reports. 15: 574. PMID 26092314 DOI: 10.1007/s11910-015-0574-9  1
2015 Winden KD, Yuskaitis CJ, Poduri A. Megalencephaly and macrocephaly Seminars in Neurology. 35: 277-287. DOI: 10.1055/s-0035-1552622  1
2013 Poduri A, Heinzen EL, Chitsazzadeh V, Lasorsa FM, Elhosary PC, LaCoursiere CM, Martin E, Yuskaitis CJ, Hill RS, Atabay KD, Barry B, Partlow JN, Bashiri FA, Zeidan RM, Elmalik SA, et al. SLC25A22 is a novel gene for migrating partial seizures in infancy. Annals of Neurology. 74: 873-82. PMID 24596948 DOI: 10.1002/ana.23998  1
2013 Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, ... ... Yuskaitis CJ, et al. De novo mutations in epileptic encephalopathies. Nature. 501: 217-21. PMID 23934111 DOI: 10.1038/nature12439  1
2010 Yuskaitis CJ, Beurel E, Jope RS. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome. Biochimica Et Biophysica Acta. 1802: 1006-12. PMID 20600866 DOI: 10.1016/j.bbadis.2010.06.015  1
2010 Mines MA, Yuskaitis CJ, King MK, Beurel E, Jope RS. GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. Plos One. 5: e9706. PMID 20300527 DOI: 10.1371/journal.pone.0009706  1
2010 Yuskaitis CJ, Mines MA, King MK, Sweatt JD, Miller CA, Jope RS. Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome. Biochemical Pharmacology. 79: 632-46. PMID 19799873 DOI: 10.1016/j.bcp.2009.09.023  1
2009 Yuskaitis CJ, Jope RS. Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cellular Signalling. 21: 264-73. PMID 19007880 DOI: 10.1016/j.cellsig.2008.10.014  1
2009 Min WW, Yuskaitis CJ, Yan Q, Sikorski C, Chen S, Jope RS, Bauchwitz RP. Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential. Neuropharmacology. 56: 463-72. PMID 18952114 DOI: 10.1016/j.neuropharm.2008.09.017  1
2007 Jope RS, Yuskaitis CJ, Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochemical Research. 32: 577-95. PMID 16944320 DOI: 10.1007/s11064-006-9128-5  1
Show low-probability matches.